New findings highlight the role of endothelial cell activation in children with cerebral malaria

Mar 20, 2009

Researchers have identified a novel pathway that may contribute to the high mortality associated with severe malaria in sub-Saharan African children. The study, published March 20 in the open-access journal PLoS Pathogens, reports that severe Plasmodium falciparum infection results in disruption of the endothelium, causing release of ultra-large von Willebrand factor (VWF) protein. Together with reduced levels of VWF-specific cleaving enzyme ADAMTS13, this finding may contribute to our knowledge of the pathophysiology of malaria.

Severe P. falciparum is responsible for an estimated 1 million deaths each year in sub-Saharan African . In spite of this significant mortality, the mechanisms underlying the clinical development of severe malaria remain poorly understood. However, studies have shown that red cells (erythrocytes) infected with malaria parasites can adhere to the inner lining (endothelium) of small blood vessels. In this study, an international group of researchers, led by Dr. James O'Donnell of Trinity College Dublin, investigate the significance of this interaction between the infected erythrocytes and the blood vessel wall.

Over a one-year period, the group studied children under six years with severe P. falciparum malaria at the Komfo Anokye hospital in Kumasi, Ghana. In blood samples from these children, the researchers found that plasma levels of a specific adhesive protein, VWF, were markedly increased. The VWF protein is synthesized within , and plays a critical role in tethering circulating blood cells to the at sites of injury. In order to prevent excessive , VWF activity in the blood is normally tightly regulated by ADAMTS13. In the Ghanaian children, the plasma levels of this important enzyme were also found to be significantly reduced.

Thus, severe P. falciparum infection causes disruption of the endothelium, resulting in the release of large amounts of VWF into the blood. Moreover, this VWF protein cannot be inactivated due to a concurrent decrease in plasma ADAMTS13 enzyme levels. Further studies will be required to define the role played by the abnormal, highly adhesive VWF in mediating the critical small-vessel obstruction associated with severe malaria. Nevertheless, these findings shed new light on the mechanisms underlying the interaction between the malaria parasite and its human host, and are not only of scientific interest, but may also create future new therapeutic opportunities for these children.

More information: Larkin D, de Laat B, Jenkins PV, Bunn J, Craig AG, et al. (2009) Severe Plasmodium falciparum Malaria Is Associated with Circulating Ultra-Large von Willebrand Multimers and ADAMTS13 Inhibition. PLoS Pathog 5(3): e1000349. doi:10.1371/journal.ppat.1000349, dx.plos.org/10.1371/journal.ppat.1000349

Source: Public Library of Science (news : web)

Explore further: Researchers take 'first baby step' toward anti-aging drug

add to favorites email to friend print save as pdf

Related Stories

How adhesive protein causes malaria

Sep 25, 2007

Researchers at the Swedish medical university Karolinska Institutet (KI) and the Swedish Institute for Infectious Disease Control (SMI) have identified the biochemical mechanism behind the adhesive protein that give rise ...

Plasmodium vivax -- challenging the dogma of being 'benign'

Jun 17, 2008

Plasmodium. vivax can cause severe malaria associated with substantial morbidity and mortality, show two studies published in PLoS Medicine this week. These findings challenge the current dogma that P. falciparum can be sev ...

How the malaria parasite hijacks human red blood cells

Jul 08, 2008

A new study—done on a scale an order of magnitude greater than anything previously attempted in the field of malaria—has uncovered an arsenal of proteins produced by the malaria parasite that allows it to hijack and remodel ...

Supplementary approach to malaria

Feb 05, 2008

Could a simple vitamin A and zinc supplement help protect young children from malaria? A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.

Recommended for you

Biomedical team creates 'nerve on a chip'

Dec 24, 2014

Michael J. Moore and J. Lowry Curley first met in the laboratory as professor and student. Now the two Tulane University researchers have started a new biomedical company that's winning praise and awards.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.